IXIARO is a vaccine used to prevent Japanese encephalitis, a viral infection transmitted by mosquitoes. It's primarily recommended for travelers or residents in regions where the disease is common, such as parts of Asia and the Western Pacific. The vaccine stimulates the immune system to produce antibodies against the Japanese encephalitis virus, offering protection against the disease. It's typically given in two doses, with a booster recommended for ongoing or repeated exposure. Always consult with a healthcare provider to determine if IXIARO is appropriate based on travel plans and risk factors.
Who needs the IXIARO Japanese Encephalitis Vaccine
IXIARO is a vaccine designed to protect against Japanese Encephalitis (JE), a potentially severe viral infection transmitted by mosquitoes. It is particularly relevant for the following groups:
1. Travelers
-
Region: Individuals traveling to areas where Japanese Encephalitis is common, primarily in rural parts of Asia and the western Pacific.
-
Duration: Particularly those who plan to stay for long periods or engage in outdoor activities in endemic areas.
2. Military Personnel
- Stationed in endemic regions where the risk of exposure to the JE virus is higher.
3. Expatriates
- People moving to or living in areas with known risks of JE transmission.
4. Laboratory Workers
- Those who might be exposed to the JE virus in a lab setting.
5. Residents of Endemic Areas
- In certain cases, residents in endemic regions, especially during outbreaks.
Considerations
-
Vaccination Schedule: Typically involves two doses, administered 28 days apart.
-
Consultation: Individuals should consult healthcare providers for advice tailored to their specific travel plans and health conditions.
IXIARO provides crucial protection for those at risk of exposure to the Japanese Encephalitis virus, helping prevent serious health outcomes.
Skip to content
